Icon Wealth Advisors LLC Acquires 8,378 Shares of IQVIA Holdings Inc. (NYSE:IQV)

Icon Wealth Advisors LLC boosted its stake in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 1,608.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,899 shares of the medical research company's stock after acquiring an additional 8,378 shares during the quarter. Icon Wealth Advisors LLC's holdings in IQVIA were worth $2,109,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. First Foundation Advisors raised its holdings in shares of IQVIA by 3.8% in the second quarter. First Foundation Advisors now owns 1,161 shares of the medical research company's stock valued at $245,000 after purchasing an additional 43 shares during the last quarter. Invera Wealth Advisors LLC increased its stake in IQVIA by 0.3% in the 2nd quarter. Invera Wealth Advisors LLC now owns 14,506 shares of the medical research company's stock valued at $3,183,000 after buying an additional 46 shares during the last quarter. Covestor Ltd boosted its stake in shares of IQVIA by 45.3% during the 1st quarter. Covestor Ltd now owns 154 shares of the medical research company's stock worth $39,000 after buying an additional 48 shares during the last quarter. Oregon Public Employees Retirement Fund grew its holdings in shares of IQVIA by 0.3% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 15,668 shares of the medical research company's stock valued at $3,313,000 after acquiring an additional 48 shares in the last quarter. Finally, Continuum Advisory LLC increased its position in shares of IQVIA by 3.3% in the second quarter. Continuum Advisory LLC now owns 1,538 shares of the medical research company's stock valued at $325,000 after acquiring an additional 49 shares during the last quarter. 89.62% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other IQVIA news, insider Eric Sherbet sold 1,300 shares of the stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $246.33, for a total transaction of $320,229.00. Following the sale, the insider now directly owns 19,536 shares in the company, valued at $4,812,302.88. This represents a 6.24 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.60% of the stock is currently owned by company insiders.

IQVIA Stock Performance

Shares of IQV traded up $4.22 during mid-day trading on Friday, hitting $201.82. 1,887,846 shares of the company's stock were exchanged, compared to its average volume of 2,206,617. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.76. IQVIA Holdings Inc. has a 52 week low of $187.62 and a 52 week high of $261.73. The stock's 50-day simple moving average is $222.67 and its 200-day simple moving average is $227.18. The firm has a market cap of $36.63 billion, a price-to-earnings ratio of 26.49, a price-to-earnings-growth ratio of 2.03 and a beta of 1.51.

Analyst Ratings Changes

IQV has been the subject of a number of analyst reports. Argus upgraded IQVIA to a "strong-buy" rating in a research note on Wednesday, July 31st. Redburn Atlantic assumed coverage on shares of IQVIA in a research note on Monday, October 14th. They issued a "buy" rating and a $276.00 target price for the company. StockNews.com raised shares of IQVIA from a "hold" rating to a "buy" rating in a research report on Wednesday. Royal Bank of Canada reissued an "outperform" rating and issued a $270.00 price objective on shares of IQVIA in a research report on Friday, November 1st. Finally, Barclays dropped their target price on shares of IQVIA from $260.00 to $255.00 and set an "overweight" rating on the stock in a report on Friday, November 1st. Four analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, IQVIA has a consensus rating of "Moderate Buy" and a consensus price target of $256.50.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.